Leading the way to safer medication

Apraclonidine

Lopidine

IOPIDINE

Therapeutic Indications

Apraclonidine is indicated for:

Chronic glaucoma

Irrespective of gender only Adults (18 years old or older)

Apraclonidine is indicated for short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Ophthalmic - 3 drops in 3 divided doses daily

Contraindications

Active ingredient Apraclonidine is contraindicated in the following cases:

Monoamine oxidase inhibitors

No gender/age discrimination

Tricyclic antidepressants

No gender/age discrimination

Systemic sympathomimetics

No gender/age discrimination